Objective: The aim of this study was to examine cardiac dysfunction during the first 2 weeks after isolated traumatic brain injury and its association with in-hospital mortality. Design: Retrospective. Setting: Level 1 regional trauma center. Patients: Adult patients with severe traumatic brain injury. Methods: After institutional review board approval, data from adult patients with isolated traumatic brain injury who underwent echocardiography during the first 2 weeks after traumatic brain injury between 2003 and 2010 were examined. Patients with preexisting cardiac disease were excluded. Clinical characteristics and echocardiogram reports were abstracted. Cardiac dysfunction was defined as left ventricular ejection fraction less than 50% or presence of regional wall motion abnormality. Interventions: None. Measurement and Main Results: We examined data from 139 patients with isolated traumatic brain injury who underwent echocardiographic evaluation. Patients were 58 ± 20 years old, 66% were male patients, and 62.6% had subdural hematoma; admission Glasgow Coma Scale score was 3 ± 1 (3-15) and head Abbreviated Injury Scale was 4 ± 1 (2-5). Of this cohort, 22.3% had abnormal echocardiogram: reduced left ventricular ejection fraction was documented in 12% (left ventricular ejection fraction, 43% ± 8%) and 17.5% of patients had a regional wall motion abnormality. Hospital day 1 was the most common day of echocardiographic exam.
T raumatic brain injury (TBI) affects over 1.8 million people annually carrying with it significant morbidity, mortality, and economic cost (1) . Despite the frequency with which TBI affects the general population and the high prevalence of secondary end-organ dysfunction after TBI, its potential impact on cardiac function has received little attention outside of case reports and small case series (2, 3) . Nonetheless, significant brain-heart interactions and paroxysmal sympathetic hyperactivity are observed in other neurologic conditions (4, 5) . In similar ways, TBI may negatively influence cardiac function and may have its own downstream impact on physiologic endpoints and patient outcomes.
Abnormal intracranial pressure resulting from intracranial lesions has been reported to cause cardiac dysfunction in experimental models (6) (7) (8) , and myocardial damage has been reported to be independently associated with increased mortality (9) (10) (11) in a variety of other neurologic conditions (12) (13) (14) (15) (16) . However, it is unknown what, if any, effects these brain-heart interactions may have on morbidity and/or mortality associated with TBI. This gap in knowledge is important to bridge as part of broad efforts to limit secondary insults after TBI, which may, if left untreated, result in secondary injury and avoidable poor outcomes. The main aim of this study was to examine cardiac dysfunction during the first 2 weeks after TBI and its association with in-hospital mortality. We hypothesized that isolated TBI is associated with cardiac dysfunction and that cardiac dysfunction is independently associated with in-hospital mortality following TBI.
Study Population
Eligibility criteria included 1) age more than or equal to 18 years old, 2) discharge diagnosis of TBI (International Classification of Diseases, 9th Edition, codes 800-801.9, 803-804.9, or 850-854.1), and 3) presence of transthoracic or transesophageal echocardiography report documented by cardiologists within 14 days after TBI. Exclusion criteria were presence of extracranial injuries (such as but not limited to orthopedic/ chest/cardiac/abdominal/pelvis), preexisting cardiac disease (defined as documented preadmission myocardial ischemia/ infarction, arrhythmia, heart failure, untreated hypertension, and cardiac pacemaker), and brain death. Figure 1 describes the data sources and data linkages performed to obtain the final sample of isolated patients with TBI who underwent echocardiography. Briefly, data sources were the HMC Trauma Registry, HMC billing data, and HMC electronic medical records. A list of eligible patients were identified from the HMC Trauma Registry and linked to HMC billing data to yield a final list of isolated TBI patients who underwent echocardiography.
Data Sources
Clinical Care of Patients With Severe TBI TBI was categorized as mild (Glasgow Coma Scale [GCS], [13] [14] [15] , moderate (GCS, 9-12), and severe (GCS, 3-8) (17) and categorized by head Abbreviated Injury Scale (AIS): 1 = minor, 2 = moderate, 3 = serious, 4 = severe, 5 = critical, and 6 = unsurvivable (18), as previously described. During the study period, patients were resuscitated according to institutional practice, consistent with the Brain Trauma Foundation Guidelines (19, 20) during that period. Relevant to this study, practice includes invasive intracranial pressure monitoring, maintaining intracranial pressure less than 20 mm Hg, minimum cerebral perfusion pressure (CPP) of 50 mm Hg, Paco 2 35-40 mm Hg, Sao 2 more than 90%, and maintaining core body temperature between 35°C and 37.5°C with antipyretics, cooling/warming blankets, or intravascular cooling devices if needed. Practices involving requests for echocardiography were not standardized during the time of this study, and echocardiography was requested at the discretion of the primary attending intensivist.
Outcome Measures
Main outcomes were presence or absence of abnormal echocardiography findings (left ventricular ejection fraction [LVEF] less than 50% or regional wall motion abnormality
[RWMA] grades 0 = none, 1+ = hypokinesis, 2+ = severe hypokinesis, 3+ = akinesis, 4+ = dyskinesis) (21) and in-hospital mortality. We also recorded frequency of echocardiography and, when available, cardiac enzyme data (elevated enzyme levels being defined as creatine kinase MB isoenzyme [CK-MB] > 9 ng/mL, troponin I > 0.4 ng/mL, or B-type natriuretic peptide [BNP] > 101 pg/mL as per institutional norms) during the first 14 days after injury. We documented the presence of any ICU hypotension, defined as systolic blood pressure (SBP) less than 90 mm Hg.
Statistical Analyses
Statistical analyses were performed using SPSS 19.0 (Chicago, IL). Descriptive statistics were used to describe clinical characteristics, echocardiography utilization, echocardiographic findings, CT scan lesions, and mortality of patients with TBI who underwent echocardiography. Data are presented as mean and (sd) for parametric data or median and sem for nonparametric data or as percentages for categorical variables.
Univariate analysis was used to examine the relationship between the outcome (abnormal echocardiography) and a priori selected demographic factors (age and gender), injury severity factors (head AIS and GCS), and cardiac factors (hypotension [emergency department (ED) and ICU] and cardiac enzymes). Factors that had p value of less than 0.2 level in univariate analysis were included in multivariate logistic regression analysis, and only the significant (p < 0.05) factors were captured in the final model for this analysis (outcome abnormal echocardiography).
We developed a second logistic regression model that was used to examine whether abnormal echocardiography was associated with in-hospital mortality after adjusting all confounders by change-in-estimate (CE) method. The potential confounders were age, gender, admission GCS, head AIS, Injury Severity Score, cardiac enzymes, ED hypotension, and ICU hypotension. We calculated two odds ratios (ORs) of the effect of abnormal echo on mortality, one which is adjusted for potential confounders and the other unadjusted. If two ORs differ by 10%, we concluded that the factor is a confounder. Age, gender, and head AIS met the CE criterion more than or equal to 10%. The final multivariate logistic regression model assessed the association of abnormal echo and mortality after adjusting for confounders. Data are described using crude and adjusted ORs with 95% CI.
RESULTS

Patient Characteristics and Final Sample
Data from 139 patients with isolated TBI whose medical record contained at least one echocardiography report ( Table 1) were reviewed. Patients meeting eligibility criteria were 58 ± 20 years old, and 66% were male patients. Most patients had severe TBI (56.1%) followed by mild TBI (36.7%). Median GCS was 3 ± 1 (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . One hundred sixteen patients (83.5%) had head AIS 4-6. The majority of patients had subdural hematoma (62.6%) followed by subarachnoid hemorrhage (16.5%), contusion (8.6%), intraparenchymal hemorrhage (4.4%), and others (7.9%) on head CT scan, and overall all cause in-hospital mortality was 13.7%.
Echocardiography Utilization and Findings
One hundred thirty-three of the 139 patients with echocardiography data (95.7%) underwent one echocardiographic examination, whereas six patients had two examinations. Overall, the median time to echocardiography was 3 days (range, 0-14 d) after TBI. The most common day of echocardiography was hospital day 1 (30, 22%). The distribution of timing of echocardiographic evaluation was hospital day 1 (admission), 3 days after TBI (76, 54.7%), 4-7 days after TBI (36, 25.9%), and 8-14 days after TBI (27, 19 .4%). One hundred thirtythree patients (96%) underwent transthoracic only, and one patient underwent transesophageal echocardiography only. Five patients (4%) underwent both transthoracic and transesophageal echocardiography on the same day. Table 1 shows the findings of the first echocardiographic report. Overall, 22.3% TBI patients with echocardiograms had cardiac dysfunction: reduced LVEF was documented in 12% of patients (LVEF 43% ± 8%) and 17.5% patients had a RWMA. Eighteen of the 139 patients (12.9%) were receiving vasopressors/inotropes on the day of echocardiography for hypotension prior to echocardiography; five of these 18 patients (27.8%) had abnormal echocardiogram (three reduced LVEF, one RWMA, and one reduced LVEF and RWMA). Of these five patients, one patient received phenylephrine, two patients received dopamine, and two patients received norepinephrine. IV dobutamine was added to the vasopressor regimen for one patient previously receiving IV phenylephrine for treatment of hypotension after echocardiography findings revealed reduced LVEF (34%). None of the 18 patients had hypotension on day of echocardiogram.
Cardiac Enzymes
Some patients who underwent echocardiography had sampling for cardiac enzymes within the 2 weeks after admission. Of the 98 of 139 patients who had CK-MB drawn, 30 patients (30.6%) had elevated CK-MB levels. Thirteen of these 30 patients (43.3%) had abnormal echocardiography. Twenty-four of the 107 patients (22.4%) sampled for troponin I had elevated troponin I levels. Twelve of these 24 patients (50%) had abnormal echocardiography. Nineteen of 25 patients who underwent BNP sampling (76%) had elevated BNP levels. Eleven of these 19 patients (57.9%) had abnormal echocardiography. There was no relationship between TBI severity (admission GCS or head AIS scores) and elevated cardiac enzymes.
Cardiac Dysfunction After TBI and In-Hospital Mortality
Univariate risk factors associated with abnormal echocardiography and in-hospital mortality are given in Table 2 . Abnormal echocardiographic evaluation at all three time points examined (within 3, 7, and 14 d after TBI) was associated with in-hospital mortality (p = 0.01, 0.01, and < 0.001, respectively). The distribution of cardiac dysfunction was 25% (19 of 76 patients) 1-3 days after TBI, 19.4% (seven of 36 patients) 4-7 days after TBI, and 18.5% (five of 27 patients) 8-14 days after TBI. The distribution of abnormal echocardiograms by TBI severity when defined by GCS was equally high: severe (24.4%, 19 of 78 patients), moderate (20%, two of 10 patients), and mild (19.6%, 10 of 51 patients). When patients were categorized by head AIS, cardiac dysfunction by echocardiogram occurred in 25.9% of patients (30 of 116 patients) who had head AIS 4-6 versus 4.3% of patients (one of 23 patients) with head AIS 1-3. Thirty-six of 139 patients (25.9%) had documented hypotension (SBP < 90 mm Hg) during their ICU stay, and one patient had both a documented myocardial infarction and an abnormal echocardiogram. Nineteen of 36 patients with hypotension (52.8%) had abnormal echocardiograms. Overall, two patients Multivariate risk factors for cardiac dysfunction during the first 2 weeks after TBI included age more than or equal to 65 years old, elevated cardiac enzymes (CK-MB and troponin I), and head AIS 4-6 ( Table 3) .
Abnormal echocardiography during this period was associated with increased in-hospital mortality. Crude OR was 14.14 (95% CI, 3.53-56.72). Age, head AIS, and gender were considered confounders, and after adjusting for these confounders, abnormal echocardiography was associated with increased inhospital mortality (adjusted OR, 9.6 [95% CI, 2.3-40.2]).
DISCUSSION
The two main findings of this study are that patients with isolated TBI, including some who were receiving vasopressors, had cardiac dysfunction within 2 weeks after isolated TBI and that TBI-related cardiac dysfunction was associated with inhospital mortality. Elevated cardiac enzymes occurred within 2 weeks after TBI, and elevated CK-MB and troponin I were associated with abnormal echocardiography. This is the first clinical study to document cardiac dysfunction and its association with in-hospital mortality after TBI.
Neurologic injury has been linked to cardiac dysfunction in a variety of models of brain injury, including emotional stress, ischemic insults, and subarachnoid hemorrhage (10, 16, 17) . Although the existence of echocardiographic abnormalities in patients with TBI is a novel finding, the idea of brain-heart interactions has been described for decades (18) . The proposed pathophysiologic mechanisms for this interaction have centered on a sudden catecholamine excess state and, more recently, the inflammatory cascade (22, 23) . Similar underlying mechanism may explain isolated neurogenic pulmonary edema (24) and stress cardiomyopathy (25) , likely due to heterogeneous vascular receptor interactions in the setting of a catecholamine excess state. In fact, left ventricular dysfunction as evidenced by a diminished LVEF and new regional wall motion abnormalities can be found even in a significant number of brain-dead patients considered donors for solid organ transplantation (26, 27) . Myocardial biopsy specimens from patients diagnosed with brain death show pathologic features indicative of catecholamine-induced injury, similar to features observed in patients diagnosed with stress cardiomyopathy (28) . Although we do not have data to demonstrate sudden catecholamine excess and did not include data from patients with brain death in this analysis, it is conceivable that the echocardiographic abnormalities observed in TBI are a variant of stress cardiomyopathy secondary to an acutely injured brain.
Although we observed cardiac dysfunction up to 2 weeks after TBI, it is possible that the dysfunction had set in earlier in the course of TBI but was overtly manifest and/or recognized only after echocardiographic documentation, the timing of which could be affected by numerous logistic factors. Our observation of cardiac dysfunction later in the course of TBI beyond the first 72 hours may, in fact, reflect persistent rather than new onset dysfunction although we cannot confirm this for the lack of serial echocardiograms. Irrespective, however, cardiac dysfunction was not uncommon in patients where it was clinically suspected leading to echocardiographic evaluation. Echocardiography timing and utilization was driven by clinical care needs and not by study design and may have been affected by provider preference. Our observations indicate a tendency for the intensivists to order echocardiograms for patients with TBI who are older and have more severe TBI (lower GCS and higher head AIS) and hypotension. Therefore, true rates for cardiac dysfunction in TBI could be different than represented by our results. Due to selection bias, the prevalence may be an overestimation of the true prevalence. Conversely, it is conceivable that some patients who did not survive and who did not have echocardiograms also had cardiac dysfunction. Although we may have residual confounding from other ICU events and cannot definitively determine whether echocardiography altered clinical practice and improved outcomes, this is a subject for future study. Future work can be framed based on these findings that document cardiac dysfunction in TBI. Our results also indicate that it may be possible for clinicians to predict cardiac dysfunction (and hence, the need for echocardiograms) based on select clinical characteristics, namely age 65 years old or older, elevated cardiac enzymes (CK-MB and troponin I), and head AIS 4-6.
Cardiac injury after other forms of acute brain injury, such as subarachnoid hemorrhage, is evidenced by elevated troponin levels and decreased LVEF (29, 30) . Patients with more severe forms of subarachnoid hemorrhage appear to be at greater risk for cardiac dysfunction (31) , and LV dysfunction after subarachnoid hemorrhage increases the risk of cerebral infarction from vasospasm, hypotension, and pulmonary edema (31) . In patients without preexisting heart disease suffering an aneurysmal subarachnoid hemorrhage, elevations in troponin I have been reported to be both sensitive and specific for myocardial dysfunction by echocardiography (32) (33) (34) , whereas elevated CK-MB levels have been reported to be highly specific (32) (33) (34) but lack sensitivity (34, 29) . Examining the scope of the role of cardiac enzymes in predicting in-hospital mortality was beyond the scope of this project but may warrant future investigation. Pharmacologic elevation of blood pressure is frequently used in patients with TBI to prevent or treat cerebral ischemia by either treating hypotension or augmenting CPP. However, data on vasopressor effectiveness in this setting are limited, and the results are conflicting despite the significant differences in pharmacodynamic profiles of vasopressor agents. Although norepinephrine has mixed effects on α-and β-adrenergic receptors, it may be more effective in augmenting CPP than selective α1-adrenergic agonist (e.g., phenylephrine), suggesting that improved cardiac output may influence cerebral perfusion and that cardiac dysfunction may hinder CPP (35) . The findings of this study indicate that myocardial dysfunction may not be uncommon after TBI even in patients with no previously known cardiac disorders and may have to be accounted for in evaluating vasopressor effectiveness. As the information about cardiac dysfunction may affect vasopressor choice, these findings also point toward the potential utility of echocardiography in evaluating cardiac function after TBI to make rationale and informed vasopressor choices. Furthermore, as cardiac dysfunction was associated with mortality, there may be a role for myocardial protection in addition to neuroprotection after TBI.
CONCLUSIONS
In summary, this preliminary study suggests that cardiac dysfunction in the setting of TBI occurs and may be associated with increased in-hospital mortality. This finding raises the question as to whether there are uncharted opportunities for a more timely recognition of cardiac dysfunction and subsequent optimization of the hemodynamic management of these patients.
